Veeva Systems Q4 Earnings Exceed Expectations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy VEEV?
Source: seekingalpha
- Strong Earnings Report: Veeva Systems reported a Q4 non-GAAP EPS of $2.06, beating expectations by $0.12, which highlights the company's robust profitability and strengthens its market position in the life sciences sector.
- Significant Revenue Growth: The company achieved Q4 revenues of $835.95 million, a 16% year-over-year increase, surpassing the market consensus of $846.45 million, reflecting strong demand and market acceptance for its subscription services.
- Positive Future Outlook: Veeva projects total revenues for Q1 FY2026 to be between $855 million and $858 million, with non-GAAP operating income expected between $378 million and $381 million, indicating confidence in future growth.
- Updated Annual Guidance: The company updated its guidance for FY2027, forecasting total revenues between $3.585 billion and $3.6 billion, with a non-GAAP EPS of approximately $8.85, demonstrating Veeva's strategic commitment to expanding market share and enhancing profitability.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VEEV?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VEEV
Wall Street analysts forecast VEEV stock price to rise
23 Analyst Rating
16 Buy
6 Hold
1 Sell
Moderate Buy
Current: 185.910
Low
222.00
Averages
317.10
High
380.00
Current: 185.910
Low
222.00
Averages
317.10
High
380.00
About VEEV
Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. It offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and the strategic business functions from research and development (R&D) through commercialization. Its four product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes, and partners across content management, training, quality management, assurance, and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Veeva Data Cloud is a data platform comprised of connected reference data, deep data, and transaction data.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Carillon Eagle Fund Q4 2025 Investor Letter Highlights
- Mixed Midcap Performance: In Q4 2025, midcap stocks showed mixed results, with the Russell Midcap Growth Index declining by 3.70% while the Russell Midcap Value Index rose by 1.41%, indicating varying investor responses to different styles that could influence asset allocation decisions.
- Sector Return Disparities: Within the growth index, the materials sector led with a 17.51% absolute return, yet its limited weight in the index restricted its overall contribution, highlighting the importance of sector selection in investment strategies.
- Veeva Systems' Market Position: Veeva Systems Inc. (NYSE:VEEV) was highlighted in the investor letter despite a 15.47% decline over the past 52 weeks; the company is addressing competitive pressures by launching AI products, showcasing its deep expertise in life sciences and potential for market share recovery.
- Future Market Outlook: Carillon Eagle Fund expresses optimism for equity markets in 2026, identifying potential opportunities in Cyclicals, Healthcare, Information Technology, Financials, and Consumer Spending sectors, which may provide new growth avenues for investors.
See More
Veeva Systems Set to Announce Q4 Earnings on March 4
- Earnings Announcement: Veeva Systems is set to release its Q4 fiscal year 2024 earnings on March 4 after market close, with consensus EPS estimates at $1.94, reflecting an 11.5% year-over-year growth, indicating the company's ongoing growth potential in the biopharmaceutical sector.
- Revenue Expectations: The anticipated revenue for Q4 is $810.95 million, representing a 12.5% year-over-year increase, which suggests strong performance in customer demand and market share, potentially solidifying its leadership position in the industry.
- Performance Beat Record: Over the past two years, Veeva has beaten EPS estimates 88% of the time and revenue estimates 100% of the time, showcasing a consistent performance that enhances investor confidence and may positively impact stock prices.
- Estimate Revision Trends: In the last three months, EPS estimates have seen two upward revisions and no downward adjustments, while revenue estimates have experienced four upward revisions and one downward, indicating a market optimism regarding Veeva's future performance that could attract more investor interest.
See More
Veeva Systems Surges 8% After Strong Q4 Results and FY27 Guidance
- Strong Earnings Report: Veeva Systems reported Q4 FY2026 revenue of $835.95 million, exceeding market expectations by $25 million, highlighting the company's robust performance in the life sciences sector.
- Upgraded Revenue Guidance: The company projects FY2027 revenue between $3.585 billion and $3.6 billion, surpassing the consensus estimate of $3.56 billion, indicating strong future growth potential.
- Earnings Per Share Growth: The non-GAAP EPS for FY2026 was $2.06, up 19% from $1.74 in the prior year, reflecting a significant improvement in the company's profitability.
- Increased Cash Reserves: As of January 31, 2026, Veeva's cash and short-term investments reached $6.6 billion, a 27% increase from $5.2 billion in 2025, providing strong financial support for future investments and expansion.
See More
Veeva Systems Reports Increased Q4 Earnings
- Significant Earnings Growth: Veeva Systems reported a fourth-quarter profit of $244.20 million, or $1.45 per share, marking a substantial increase from last year's $195.62 million and $1.18 per share, indicating strong market performance.
- Adjusted Earnings Improvement: Excluding items, Veeva's adjusted earnings reached $346.12 million, or $2.06 per share, reflecting successful cost control and operational efficiency, which further boosts investor confidence.
- Strong Revenue Growth: The company's revenue for the fourth quarter rose 16% year-over-year to $835.95 million, up from $720.88 million last year, demonstrating sustained demand for its products and services in the market.
- Optimistic Future Outlook: Veeva's guidance for the next quarter projects earnings per share between $2.13 and $2.14, with revenue expected to range from $855 million to $858 million, showcasing the company's confidence in future growth and market potential.
See More
Veeva Systems Q4 Results Exceed Expectations, Shares Surge
- Strong Financial Performance: Veeva Systems reported Q4 revenue of $836 million, a 16% year-over-year increase, surpassing the market expectation of $810.6 million, indicating robust growth potential in the cloud software sector.
- Improved Profitability: The earnings per share reached $2.06, exceeding analyst estimates of $1.93, reflecting the company's ongoing improvement in profitability and boosting investor confidence.
- Expanding Customer Base: Veeva Systems ended the quarter with 1,552 customers, indicating an increasing market penetration in the life sciences sector, which further solidifies its market leadership position.
- Optimistic Future Guidance: The company forecasts Q1 revenue between $855 million and $858 million, exceeding analyst expectations of $847.2 million, demonstrating strong business momentum and confidence in future growth.
See More
Veeva Systems Reports 16% Revenue Growth for FY 2026
- Fiscal Year Revenue Growth: Veeva Systems reported total revenues of $3.195 billion for FY 2026, marking a 16% year-over-year increase, which underscores the company's robust growth momentum in the life sciences sector and solidifies its market leadership.
- Subscription Revenue Performance: Subscription revenues reached $2.684 billion for FY 2026, up 17% year-over-year, reflecting sustained demand for its industry cloud solutions from clients, which is expected to drive future revenue growth.
- Fourth Quarter Results Exceed Expectations: The fourth quarter of FY 2026 saw total revenues of $836 million, also up 16% year-over-year, surpassing market expectations and indicating strong execution and adaptability across all business areas.
- Optimistic Future Outlook: Veeva aims for a $6 billion revenue run rate by 2030, with the CEO highlighting the integration of industry-specific AI as a significant value creator, demonstrating confidence in future growth prospects.
See More
Carillon Eagle Fund Q4 2025 Investor Letter Highlights
- Mixed Midcap Performance: In Q4 2025, midcap stocks showed mixed results, with the Russell Midcap Growth Index declining by 3.70% while the Russell Midcap Value Index rose by 1.41%, indicating varying investor responses to different styles that could influence asset allocation decisions.
- Sector Return Disparities: Within the growth index, the materials sector led with a 17.51% absolute return, yet its limited weight in the index restricted its overall contribution, highlighting the importance of sector selection in investment strategies.
- Veeva Systems' Market Position: Veeva Systems Inc. (NYSE:VEEV) was highlighted in the investor letter despite a 15.47% decline over the past 52 weeks; the company is addressing competitive pressures by launching AI products, showcasing its deep expertise in life sciences and potential for market share recovery.
- Future Market Outlook: Carillon Eagle Fund expresses optimism for equity markets in 2026, identifying potential opportunities in Cyclicals, Healthcare, Information Technology, Financials, and Consumer Spending sectors, which may provide new growth avenues for investors.
See More
Veeva Systems Set to Announce Q4 Earnings on March 4
- Earnings Announcement: Veeva Systems is set to release its Q4 fiscal year 2024 earnings on March 4 after market close, with consensus EPS estimates at $1.94, reflecting an 11.5% year-over-year growth, indicating the company's ongoing growth potential in the biopharmaceutical sector.
- Revenue Expectations: The anticipated revenue for Q4 is $810.95 million, representing a 12.5% year-over-year increase, which suggests strong performance in customer demand and market share, potentially solidifying its leadership position in the industry.
- Performance Beat Record: Over the past two years, Veeva has beaten EPS estimates 88% of the time and revenue estimates 100% of the time, showcasing a consistent performance that enhances investor confidence and may positively impact stock prices.
- Estimate Revision Trends: In the last three months, EPS estimates have seen two upward revisions and no downward adjustments, while revenue estimates have experienced four upward revisions and one downward, indicating a market optimism regarding Veeva's future performance that could attract more investor interest.
See More
Veeva Systems Surges 8% After Strong Q4 Results and FY27 Guidance
- Strong Earnings Report: Veeva Systems reported Q4 FY2026 revenue of $835.95 million, exceeding market expectations by $25 million, highlighting the company's robust performance in the life sciences sector.
- Upgraded Revenue Guidance: The company projects FY2027 revenue between $3.585 billion and $3.6 billion, surpassing the consensus estimate of $3.56 billion, indicating strong future growth potential.
- Earnings Per Share Growth: The non-GAAP EPS for FY2026 was $2.06, up 19% from $1.74 in the prior year, reflecting a significant improvement in the company's profitability.
- Increased Cash Reserves: As of January 31, 2026, Veeva's cash and short-term investments reached $6.6 billion, a 27% increase from $5.2 billion in 2025, providing strong financial support for future investments and expansion.
See More
Veeva Systems Reports Increased Q4 Earnings
- Significant Earnings Growth: Veeva Systems reported a fourth-quarter profit of $244.20 million, or $1.45 per share, marking a substantial increase from last year's $195.62 million and $1.18 per share, indicating strong market performance.
- Adjusted Earnings Improvement: Excluding items, Veeva's adjusted earnings reached $346.12 million, or $2.06 per share, reflecting successful cost control and operational efficiency, which further boosts investor confidence.
- Strong Revenue Growth: The company's revenue for the fourth quarter rose 16% year-over-year to $835.95 million, up from $720.88 million last year, demonstrating sustained demand for its products and services in the market.
- Optimistic Future Outlook: Veeva's guidance for the next quarter projects earnings per share between $2.13 and $2.14, with revenue expected to range from $855 million to $858 million, showcasing the company's confidence in future growth and market potential.
See More
Veeva Systems Q4 Results Exceed Expectations, Shares Surge
- Strong Financial Performance: Veeva Systems reported Q4 revenue of $836 million, a 16% year-over-year increase, surpassing the market expectation of $810.6 million, indicating robust growth potential in the cloud software sector.
- Improved Profitability: The earnings per share reached $2.06, exceeding analyst estimates of $1.93, reflecting the company's ongoing improvement in profitability and boosting investor confidence.
- Expanding Customer Base: Veeva Systems ended the quarter with 1,552 customers, indicating an increasing market penetration in the life sciences sector, which further solidifies its market leadership position.
- Optimistic Future Guidance: The company forecasts Q1 revenue between $855 million and $858 million, exceeding analyst expectations of $847.2 million, demonstrating strong business momentum and confidence in future growth.
See More
Veeva Systems Reports 16% Revenue Growth for FY 2026
- Fiscal Year Revenue Growth: Veeva Systems reported total revenues of $3.195 billion for FY 2026, marking a 16% year-over-year increase, which underscores the company's robust growth momentum in the life sciences sector and solidifies its market leadership.
- Subscription Revenue Performance: Subscription revenues reached $2.684 billion for FY 2026, up 17% year-over-year, reflecting sustained demand for its industry cloud solutions from clients, which is expected to drive future revenue growth.
- Fourth Quarter Results Exceed Expectations: The fourth quarter of FY 2026 saw total revenues of $836 million, also up 16% year-over-year, surpassing market expectations and indicating strong execution and adaptability across all business areas.
- Optimistic Future Outlook: Veeva aims for a $6 billion revenue run rate by 2030, with the CEO highlighting the integration of industry-specific AI as a significant value creator, demonstrating confidence in future growth prospects.
See More
